NCT06531434View on ClinicalTrials.gov

Establishing Best Treatment Strategy for T4 Esophageal Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Esophageal Cancer TNM Staging Primary Tumor (T) T4
Interventions
COMBINATION_PRODUCT

"Docetaxel, Cisplatin, fluorouracil, Radiation"

Induction chemotherapy with Docetaxel, Cisplatin, and fluorouracil for 4 to 8 cycles, followed by concurrent chemoradiotherapy with Cisplatin and Radiation 30.6-40 Gy.

Trial Locations (1)

704302

RECRUITING

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER